Trial results favor prasugrel over ticagrelor after coronary stenting
Prasugrel reduced major cardiovascular events to the same extent as ticagrelor but with lower major bleeding after coronary stenting in patients with acute coronary syndromes, according to results from the SWITCH SWEDEHEART ...
Aug 31, 2026
0
4









